ACR2022 - Day 1.1

Best of PsA on Day 1Dr. Rachel Tate discusses the best PSA data presented Saturday, November 12, 2002 at ACR22 Convergence. Abstract 0387: Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and ComorbidityAbstract 0377: Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies Can computers tell the difference between RA & PsA?Dr. David Liew discusses Abstract 0242 presented at ACR22 in Philadelphia, PA.Abstract 0242: Neural Networks for Distinguishing Rheumatoid Arthritis from Psoriatic Arthritis by Using Magnetic Resonance Imaging Can you use the BASDAI in Pregnancy?Dr. Eric Dein discusses abstract 0374 presented at ACR22 Convergence in Philadelphia, PA.Abstract 0374: The BASDAI Index During Pregnancy Drs Tate and Worthing What's going on on the HillSession # 12S119. Effect of voclosporin in class V lupus nephritisDr. Yusof discusses abstract 0355 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0355: Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study Microbiome and AxSPADr. Akhil Sood discusses abstract 1162 presented at ACR22 Convergence in Philadelphia, PA. Abstract 1162: Improvement of Gut Microbiota Dysbiosis in Patients with Axial Spondyloarthritis After One Year of Biological Treatment Opioids and Health Care Utilization in PsA and ASDr Aurelie Najm  discusses Abstract 0402 presented at ACR22 Convergence in Philadelphia, PA.Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS Switching Between JAK Inhibiters in RADr. Janet Pope discusses abstract 0274 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0274: Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset Treatment Choices and Mortality in RA ILd 2Dr. Julian Segen, PhiladelphiaDr. Bryant England, Philadelphia Upadacitinib vs  Adalimumab in PsA using RAPID3Dr. Catherine Sims discusses abstract 0192 presented at ACR22 Convergence. 0192: Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Psoriatic Arthritis